When was Science 37 founded?

Science 37 was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Science 37 located?

Science 37 is headquartered in Los Angeles, United States.

How many employees does Science 37 have?

As of Mar 31, 2026, the latest employee count at Science 37 is 303.

Is Science 37 a funded company?

Science 37 is a funded company, having raised a total of $106M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 20, 2015.

When was the latest funding round of Science 37?

Science 37's latest funding was a $***** Series D round on Aug 20, 2020, with participation from 10 investors.

What is the annual revenue of Science 37?

Annual revenue of Science 37 is $70.1M as on Dec 31, 2022.

Where does Science 37 rank among its competitors?

Science 37 ranks 4th amongst 293 active competitors, of which 50 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was BrightInsight, which secured $13M in Jan, 2026.

Who are the top competitors of Science 37?

Science 37's top competitors include Medidata, Verily and IQVIA. Among them, BrightInsight secured the most recent funding round in January, 2026.

Science 37 - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is Science 37 an acquired company?

Science 37 got acquired by eMed on Jan 29, 2024.

Science 37 is an acquired company based in Los Angeles (United States), founded in 2014 by Belinda Tan and Noah Craft. It operates as a Provider of a suite solution for clinical trials for researchers. Science 37 has raised $106M in funding from investors like Lux Capital, Redmile Group and Glynn Capital. The company has 293 active competitors, including 50 funded and 41 that have exited. Its top competitors include companies like Medidata, Verily and IQVIA.

Company Details

Science 37 offers end-to-end clinical trial solutions for researchers. Metasite, a clinical trial operating model of the company uses a mobile platform to allow patients to participate in the trial. The company has developed products like Science 37 Metasite that is a site-based clinical trial data collection on virtual media. The platform allows researchers to use the tool for trial management, data collection, and communication. The tool digital transformation allows users to study trail designing concepts and assist in virtualization. The tool provided by the company gives recruitment tools, patient enrollment system and more.

Website: science37.com
Social
Email ID: *****@science37.com
Phone Number: +1 **********
Part Of

Key Metrics

Founded Year

2014

Location

Los Angeles, United States

Stage

Acquired

Total Funding

$106M in 4 rounds

Latest Funding Round

Series D, Aug 20, 2020, $*****

Investors

Lux Capital & 13 more

Ranked

4^th among 293 active competitors

Annual Revenue

$70.1M as on Dec 31, 2022

Employee Count

303 as on Mar 31, 2026

Similar Companies

Medidata & 336 more

Exit Details

Acquired by eMed (Jan 29, 2024)

View Science 37's full profile

Science 37 is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
LIFESCI ACQUISITION II CORP. CIN: 1819113 , United States, Active	Apr 29, 2021	$70.1M (As on Dec 31, 2022)	460 (As on Dec 31, 2022)	-
SCIENCE 37, INC. CIN: 471784711 , United States, Active	Sep 07, 2014	-	225 (As on Dec 31, 2024)	-

Science 37 got acquired by eMed on Jan 29, 2024 at an acquisition amount of $38M. It was facilitated by William Blair, Hogan Lovells and Thompson Hine.

Click here to take a look at Science 37's acquisition in detail

Science 37 has raised a total funding of $106M over 4 rounds. Its first funding round was on Oct 20, 2015. Its latest funding round was a Series D round on Aug 20, 2020 for $*****. 10 investors participated in its latest round. Science 37 has 14 institutional investors.

Here is the list of recent funding rounds of Science 37:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 20, 2020	4081359	Series D	3232259	7079564	8926284	5788029
Apr 25, 2017	8529468	Series C	9136185	7993382	3864691	Lux Capital & 4 more
Oct 18, 2016	6235275	Series B	2558455	9429226	Redmile Group	Lux Capital & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Science 37's funding rounds and investors

The founders of Science 37 are Belinda Tan and Noah Craft.

Here are the details of Science 37's key team members:

Belinda Tan: Former Co-Founder of Science 37.
Noah Craft: Former Co-Founder of Science 37.

View details of Science 37's Founder profiles and Board Members

Science 37's employee count trend

Science 37 has 303 employees as of Mar 26. Here is Science 37's employee count trend over the years:

Uncover Science 37's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Science 37 include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Science 37, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	Verily 2015, Dallas (United States), Late Stage	Developer of precision health platforms and solutions using artificial intelligence	$2.5B	Silver Lake, Temasek & 6 others	78/100
3rd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Fisher Lynch Capital ... & 9 others	76/100
4th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Glynn Capital, Redmile Group & 12 others	73/100
5th	Viz.ai 2016, San Francisco (United States), Series D	Provider of AI-powered care coordination platform for disease detection and treatment	$252M	Insight Partners, Scale Venture Partners ... & 16 others	69/100
6th	Tempus 2015, Chicago (United States), Public	AI-based precision medicine solutions for oncology	$1.05B	T. Rowe Price, New Enterprise Associates ... & 10 others	68/100
7th	Deep 6 AI 2013, Pasadena (United States), Acquired	AI enabled solutions for clinical trials	$54.8M	Point72 Ventures, MemorialCare Innovation Fund ... & 11 others	68/100
8th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	Merck Global Health Innovation Fund, MPM Capital ... & 5 others	66/100
9th	BrightInsight 2017, San Jose (United States), Series C	Provider of digital health solutions for clinical trials	$179M	Insight Partners, New Leaf Venture Partners ... & 8 others	64/100
10th	Sanguine 2010, Los Angeles (United States), Series B	Building a databank of patient-derived data for advanced research	$5.53M	Broadoak Capital Partners, FCVC & 9 others	64/100